Jnana Therapeutics Stock
Jnana Therapeutics is a clinical-stage biotechnology company using its RAPID chemoproteomics platform to develop medicines for challenging drug targets in diseases with high unmet needs. The company focuses on creating first- and best-in-class therapies for rare and immune-mediated diseases. Its lead program, JNT-517, targets an allosteric site on SLC6A19, offering a potential first-in-class oral treatment for phenylketonuria (PKU), a rare metabolic disorder.
Sign up for SecondMarket® to view the market and buy or sell Jnana Therapeutics Stock
Buy + SellSee Jnana Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Jnana Therapeutics Stock Valuation + Share Prices
View real-time Tape D® data on Jnana Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Jnana Therapeutics Management Team
Director
Donald W. Nicholson
Director
Ronald C. Renaud
President, CEO
George Vratsanos
Director
Brian Cali
Director
Annie C. Chen
CFO
Douglas W. Pagán
Chief Business Officer
Caroline Stark Beer
Director
Matthew Hammond
CFO
James Sauer
Chief Development Officer
John Throup
Director
Carlo Rizzuto
Director
Terrance McGuire
Jnana Therapeutics Major Investors
AbbVie Ventures
Versant Ventures, Inc.
Pfizer Ventures
Bain Capital Life Sciences
Avalon Ventures, LLC
Polaris Partners
RA Capital Management LLC
Learn More About Jnana Therapeutics Stock
Buy Jnana Therapeutics Stock
01Jnana Therapeutics stock does not trade on public stock exchanges. Jnana Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Jnana Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Jnana Therapeutics Stock
02Jnana Therapeutics Stock does not trade on public stock exchanges. In order to sell Jnana Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Jnana Therapeutics Stock Price
03Jnana Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Jnana Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Jnana Therapeutics Stock Ticker Symbol
04There is no ticker symbol for Jnana Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Jnana Therapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Jnana Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Jnana Therapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Jnana Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Jnana Therapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Jnana Therapeutics IPO
08Jnana Therapeutics is a private company and has not had an IPO. There is currently no Jnana Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Jnana Therapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Jnana Therapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
